Citations

Showing 10 of 108119 citations.

Acute Kidney Injury in Patients Undergoing Total Hip Arthroplasty: A Systematic Review and Meta-Analysis
Kaewput, Wisit , Thamcharoen, Natanong , Cheungpasitporn, Wisit , Watthanasuntorn, Kanramon , Salim, Sohail Abdul , Ungprasert, Patompong , Lertjitbanjong, Ploypin , Aeddula, Narothama Reddy , Torres‐Ortiz, Aldo, Kaewput, Wisit , Aeddula, Narothama Reddy , Cheungpasitporn, Wisit , Thongprayoon, Charat , Mao, Michael A.

Mayo Clinic

Journal of Clinical Medicine | January 10, 2019 | Volume: 8 | Issue: 1 | Pages: 66

10.3390/jcm8010066 | PMID 30634487 Get It

Background: The number of total hip arthroplasties (THA) performed across the world is growing rapidly. We performed this meta-analysis to evaluate the incidence of acute kidney injury (AKI) in patients undergoing THA. Methods: A literature search was performed using MEDLINE, EMBASE and Cochrane Database from inception until July 2018 to identify studies assessing the incidence of AKI (using standard AKI definitions of RIFLE, AKIN, and KDIGO classifications) in patients undergoing THA. We applied a random-effects model to estimate the incidence of AKI. The protocol for this meta-analysis is registered with PROSPERO (no. CRD42018101928). Results: Seventeen cohort studies with a total of 24,158 patients undergoing THA were enrolled. Overall, the pooled estimated incidence rates of AKI and severe AKI requiring dialysis following THA were 6.3% (95% CI: 3.8%–10.2%) and 0.5% (95% CI: 0.1%–2.3%). Subgroup analysis based on the countries by continent was performed and demonstrated the pooled estimated incidence of AKI following THA of 9.2% (95% CI: 5.6%–14.8%) in Asia, 8.1% (95% CI: 4.9%–13.2%) in Australia, 7.4% (95% CI: 3.2%–16.3%) in Europe, and 2.8% (95% CI: 1.2%–17.0%) in North America. Meta-regression of all included studies showed significant negative correlation between incidence of AKI following THA and study year (slope = −0.37, p <0.001). There was no publication bias as assessed by the funnel plot and Egger’s regression asymmetry test with p = 0.13 for the incidence of AKI in patients undergoing THA. Conclusion: The overall estimated incidence rates of AKI and severe AKI requiring dialysis in patients undergoing THA are 6.3% and 0.5%, respectively. There has been potential improvement in AKI incidence for patients undergoing THA over time.
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
Saini, Aman , Wallace, Alex, Alzubaidi, Sadeer , Knuttinen, M. Grace , Naidu, Sailendra , Sheth, Rahul A. , Albadawi, Hassan , Öklü, Rahmi , Oklu, Rahmi

Mayo Clinic

Journal of Clinical Medicine | January 10, 2019 | Volume: 8 | Issue: 1 | Pages: 55

10.3390/jcm8010055 | PMID 30621040 Get It

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and affects millions worldwide. Due to the lack of effective systemic therapies for HCC, researchers have been investigating the use of locoregional tumor control with Yttrium-90 (Y90) radioembolization since the 1960s. Following the development of glass and resin Y90 microspheres in the early 1990s, Y90 radioembolization has been shown to be a safe and efficacious treatment for patients with HCC across Barcelona Clinic Liver Cancer (BCLC) stages. By demonstrating durable local control, good long term outcomes, and equivalent if not superior tumor responses and tolerability when compared to alternative therapies including transarterial chemoembolization (TACE) and sorafenib, Y90 radioembolization is being increasingly used in HCC treatment. More recently, investigations into variations in Y90 radioembolization technique including radiation segmentectomy and radiation lobectomy have further expanded its clinical utility. Here, we discuss the history and evolution of Y90 use in HCC. We outline key clinical trials that have established the safety and efficacy of Y90 radioembolization, and also summarize trials comparing its efficacy to existing HCC treatments. We conclude by reviewing the techniques of radiation segmentectomy and lobectomy, and by discussing dosimetry.
Bilateral Multicanal Benign Paroxysmal Positional Vertigo Coexisting with a Vestibular Schwannoma: Case Report
Karataylι-Özgürsoy, Selmin, Stamper, Greta C., Lundy, Larry, Zapala, David A.

Mayo Clinic

Ear, Nose & Throat Journal | January 10, 2019 | Volume: 90 | Issue: 1 | Pages: E10-E15

10.1177/014556131109000114 | PMID 21229492 Get It

We describe a rarely encountered case of coexisting bilateral multicanal benign paroxysmal positional vertigo (BPPV) and vestibular schwannoma in a 56-year-old woman. The patient had presented with a 10-year history of dizziness and imbalance, and her vestibular findings were perplexing. We decided on a working diagnosis of BPPV and began treatment. After several months of canalith repositioning maneuvers had failed to resolve her symptoms, we obtained magnetic resonance imaging, which revealed the presence of the vestibular schwannoma. This case serves as a reminder of the importance of differentiating between central and peripheral vestibular disorders, as well as central and anterior canal BPPV-induced down-beating nystagmus in order to establish the correct diagnosis and initiate appropriate treatment.
Bilateral Vestibular Hypofunction in Neurosarcoidosis: A Case Report
Smith, Jonathan Helmsley, Stovall, Kyndra C., Coons, Stephen W., Fife, Terry D.

Mayo Clinic

Ear, Nose & Throat Journal | January 10, 2019 | Volume: 90 | Issue: 1 | Pages: E1-E3

10.1177/014556131109000111 | PMID 21229491 Get It

We describe the case of a 59-year-old woman who presented with progressive bilateral vestibidar hypofunction and who was found to have bilateral granulomatous mass lesions of the mesial temporal lobe. Initially, her condition stabilized neurologically with corticosteroids, but a diagnosis of neurosarcoidosis was delayed because of the unusual presentation and persistently normal chest imaging results and serum angiotensin-converting enzyme (ACE) levels. Approximately 1 year after her initial presentation, the patient died of complications of a myocardial infarction and pulmonary embolism. Sarcoidosis should be considered in the differential diagnosis of idiopathic bilateral vestibular hypofunction even if the chest imaging and serum ACE levels are normal, particularly when there is evidence of a multisystem process.
Primary Mucosal Desmoplastic Melanoma of the Nasal Vestibule: The Second Case
Cervantes, Sergio S., Baugh, Reginald F.

Mayo Clinic

Ear, Nose & Throat Journal | January 10, 2019 | Volume: 90 | Issue: 10 | Pages: 483-485

10.1177/014556131109001008 | PMID 22033960 Get It

Primary mucosal desmoplastic melanoma is an exceedingly rare, potentially devastating disease that is often initially misdiagnosed because of its deceptively benign presentation. We report what we believe is only the second case of mucosal desmoplastic melanoma arising from the nasal vestibule. The patient, a 62-year-old woman, presented with an obstructive, enlarging mass in the nasal cavity. The tumor, which was initially believed to be benign, was excised, but it recurred 12 months postoperatively. The recurrence was excised, but 4 years later, the patient experienced a second recurrence; in this case, the tumor had invaded the cribriform plate and extended to the anterior cranial fossa. The tumor subsequently metastasized to the dura mater, which led to the patient's death. We review the distinction between conventional mucosal melanoma and mucosal desmoplastic melanoma, and we discuss the ways in which the behavior of a desmoplastic melanoma can point to the diagnosis. Because a diagnosis can be difficult to establish, we stress the importance of maintaining a high index of suspicion when evaluating pathologic and immunohistochemical findings in a patient with a recurrent mucosal nasal mass.
Cochlear Implant Fixation Using Resorbable Mesh
Lundy, Larry, Karataylι-Özgürsoy, Selmin

Mayo Clinic

Ear, Nose & Throat Journal | January 10, 2019 | Volume: 90 | Issue: 7 | Pages: 306-312

10.1177/014556131109000707 | PMID 21792798 Get It

In this article we describe a new method of cochlear implant receiver-stimulator fixation using a resorbable poly (D,L) lactic acid mesh. We conducted a retrospective case review at a tertiary referral center; 10 pediatric and 4 adult patients had undergone cochlear implantation during the period from February to October 2008. Resorbable poly (D,L) lactic acid mesh and pins were used for fixation of the cochlear implant receiver stimulator. The receiver stimulator was assessed for stability/migration, and the scalp flap/incision were evaluated for allergic reactions, infections, and healing problems. With an average followup of 17.2 months, no patients had migration of the receiver stimulator, and there was no evidence of infection, wound dehiscence, or allergic reaction. Early results indicate that fixation of a cochlear implant receiver stimulator using resorbable mesh is well tolerated and provides good stability without device migration. Resorbable mesh fixation of the receiver stimulator is a reasonable alternative technique for cochlear implantation.
Type 1 First Branchial Cleft Anomaly: Duplication of the External Auditory Canal
Carlson, Matthew L. , Archibald, David, Cofer, Shelagh A. , Archibald, David J.

Mayo Clinic

Ear, Nose & Throat Journal | January 10, 2019 | Volume: 90 | Issue: 7 | Pages: 302-303

10.1177/014556131109000705 | PMID 21792796 Get It

Basic and Advanced Echocardiographic Evaluation of Myocardial Dysfunction in Sepsis and Septic Shock
Vallabhajosyula, Saraschandra , Pruthi, Sonal , Shah, Siddharth , Wiley, Brandon M. , Mankad, Sunil , Vallabhajosyula, Saraschandra , Jentzer, Jacob C.

Mayo Clinic

Anaesthesia and Intensive Care | January 10, 2019 | Volume: 46 | Issue: 1 | Pages: 13-24

10.1177/0310057x1804600104 | PMID 29361252 Get It

Sepsis continues to be a leading cause of mortality and morbidity in the intensive care unit. Cardiovascular dysfunction in sepsis is associated with worse short- and long-term outcomes. Sepsis-related myocardial dysfunction is noted in 20%–65% of these patients and manifests as isolated or combined left or right ventricular systolic or diastolic dysfunction Echocardiography is the most commonly used modality for the diagnosis of sepsis-related myocardial dysfunction. With the increasing use of ultrasonography in the intensive care unit, there is a renewed interest in sepsis-related myocardial dysfunction. This review summarises the current scope of literature focused on sepsis-related myocardial dysfunction and highlights the use of basic and advanced echocardiographic techniques for the diagnosis of sepsis-related myocardial dysfunction and the management of sepsis and septic shock.
Interfer-ing with immunotherapy-induced autoimmunity
Zeng, Hu

Mayo Clinic

Science Translational Medicine | January 10, 2019 | Volume: 11 | Issue: 474 | Pages: No page available

10.1126/scitranslmed.aaw0533 Get It

Inhibition of type I IFN prevents autoimmune toxicity while preserving antitumor efficacy of combined cancer vaccine and adoptive cell therapy.